Xenon Pharmaceuticals Inc.
XENE | NASDAQ
$38.79
-$0.20 (-0.51%)
Sep 22, 2026, 2:04 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | 7.5M | 7.5M | 7.5M | 7.5M | n/a | n/a | n/a | n/a | n/a | n/a | 132K | 668K | 9.43M | 13.17M | 21.16M | 22.85M | 18.44M | 19.85M | 18.28M | 29.45M |
Cost of Revenue | 77.67M | 78.3M | 78.3M | 77.69M | 632K | n/a | 599K | 599K | 599K | 599K | n/a | n/a | 29.43M | 51.58M | 70.94M | 92.82M | 82.28M | 78.52M | 75.46M | 68.54M | 49.65M | 31.28M |
Gross Profit | -77.67M | -78.3M | -70.8M | -70.19M | 6.87M | 7.5M | -599K | -599K | -599K | -599K | n/a | n/a | -29.3M | -50.91M | -61.5M | -79.65M | -61.12M | -55.67M | -57.03M | -48.69M | -31.37M | -1.83M |
Operating Income | -441.59M | -412.66M | -373.07M | -340.78M | -318.12M | -293M | -279.3M | -255.52M | -237.52M | -224.04M | -214.05M | -203.69M | -186.13M | -160.83M | -129.14M | -110.65M | -88.12M | -80.3M | -78.99M | -67.08M | -61.18M | -39.33M |
Interest Income | 31.46M | 26.52M | 27.69M | 30.91M | 35.03M | 38.67M | 41.94M | 41.21M | 37.87M | 33.55M | 27.62M | 23.39M | 19.48M | 13.77M | 8.71M | 4.51M | 1.52M | 779K | 557K | 383K | 473K | 1.31M |
Pretax Income | -411.14M | -385.15M | -344.89M | -309.7M | -282.6M | -255.52M | -238.42M | -213.83M | -199.34M | -188.77M | -182.69M | -173.99M | -163.11M | -84.23M | -62.86M | -51.68M | -29.6M | -83.12M | -78.89M | -41.47M | -34.88M | -12.77M |
Net Income | -409.2M | -383.17M | -345.91M | -306.33M | -278.23M | -251.45M | -234.33M | -213.39M | -199.06M | -188.6M | -182.39M | -175.05M | -163.73M | -147.43M | -125.37M | -113.54M | -91.84M | -82.79M | -78.88M | -65.64M | -59.05M | -37.12M |
Selling & General & Admin | 89.1M | 84.41M | 79.63M | 75.57M | 72.99M | 73.15M | 68.31M | 62.92M | 59.02M | 51.2M | 46.54M | 42.42M | 38.45M | 35.57M | 32.81M | 31M | 27M | 24.63M | 21.97M | 18.39M | 16.76M | 13.73M |
Research & Development | 352.49M | 328.25M | 300.94M | 272.71M | 252.63M | 227.34M | 210.39M | 192M | 177.91M | 172.25M | 167.51M | 161.27M | 147.82M | 125.92M | 105.77M | 92.82M | 82.28M | 78.52M | 75.46M | 68.54M | 62.7M | 55.04M |
Other Expenses | -77.67M | -78.3M | -78.3M | -77.69M | -632K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -29.43M | -51.58M | -70.94M | -92.82M | -82.28M | -78.52M | -75.46M | -68.54M | -49.65M | -31.28M |
Operating Expenses | 363.92M | 334.36M | 302.27M | 270.59M | 324.99M | 300.5M | 278.7M | 254.92M | 236.93M | 223.45M | 214.05M | 203.69M | 156.84M | 109.92M | 67.64M | 31M | 27M | 24.63M | 21.97M | 18.39M | 29.81M | 37.5M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19K | 19K | 19K | 19K | n/a | 154K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -599K | -599K | -599K | -599K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 441.59M | 412.66M | 380.57M | 348.28M | 325.62M | 300.5M | 279.3M | 255.52M | 237.52M | 224.04M | 214.05M | 203.69M | 186.27M | 161.49M | 138.58M | 123.82M | 109.28M | 103.15M | 97.43M | 86.93M | 79.46M | 68.77M |
Income Tax Expense | -1.94M | -1.98M | 1.02M | -3.37M | -4.37M | -4.07M | -4.09M | -446K | -283K | -170K | -292K | 1.05M | 622K | 63.2M | 62.51M | 61.86M | 62.24M | -332K | -6K | -476K | -474K | -296K |
Shares Outstanding (Basic) | 99.61M | 87.35M | 79.25M | 79.25M | 78.95M | 78.69M | 78.39M | 77.93M | 77.67M | 77.59M | 69.97M | 66M | 65.86M | 65.72M | 65.66M | 62.54M | 56.19M | 53.06M | 41.19M | 41.19M | 42.09M | 36.82M |
Shares Outstanding (Diluted) | 99.61M | 87.35M | 79.25M | 79.25M | 78.95M | 78.69M | 78.39M | 77.93M | 77.67M | 77.59M | 69.97M | 66M | 65.86M | 65.72M | 65.66M | 65.47M | 56.19M | 54.85M | 41.19M | 42.27M | 42.09M | 36.82M |
EPS (Basic) | -4.74 | -4.70 | -4.36 | -3.89 | -3.55 | -3.23 | -3.02 | -2.82 | -2.74 | -2.71 | -2.72 | -2.65 | -2.51 | -2.34 | -2.08 | -2.13 | -1.91 | -1.89 | -1.95 | -1.68 | -1.56 | -1.03 |
EPS (Diluted) | -4.74 | -4.70 | -4.36 | -3.89 | -3.55 | -3.23 | -3.02 | -2.82 | -2.74 | -2.71 | -2.72 | -2.65 | -2.49 | -2.32 | -2.05 | -2.10 | -1.90 | -1.88 | -1.95 | -1.66 | -1.54 | -1.01 |
EBITDA | -416.75M | -399.03M | -359.37M | -332.1M | -315.5M | -290.36M | -276.73M | -252.73M | -233.7M | -220.26M | -210.51M | -196.6M | -180.42M | -155.34M | -123.63M | -109.27M | -86.89M | -79.22M | -78.09M | -66.24M | -59.74M | -37.36M |
EBIT | -418.59M | -401.5M | -361.91M | -334.66M | -318.12M | -293M | -279.3M | -255.52M | -237.52M | -224.04M | -214.05M | -199.8M | -182.25M | -156.94M | -125.26M | -110.65M | -88.12M | -80.3M | -78.99M | -67.08M | -60.54M | -38.1M |
Depreciation & Amortization | 1.84M | 2.47M | 2.54M | 2.57M | 2.62M | 2.63M | 2.57M | 2.79M | 3.83M | 3.79M | 3.54M | 3.21M | 1.83M | 1.6M | 1.62M | 1.38M | 1.23M | 1.09M | 906K | 838K | 800K | 736K |
Add to Watchlist
Select watchlists to add or remove XENE